Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1275-1281

  Arun Kumar, Annan Sudarsan ^a   Umamaheswaran, Gurusamy ^a   Padmapriya, Ramamoorthy ^a   Balachandar, Jayaraman ^a   Adithan, Chandrasekaran ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

AMI; eNOS; NO; NOS3; Polymorphism; South Indian population

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE 3; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NOS3 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MODELS, GENETIC; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEQUENCE ANALYSIS, DNA;

EID: 84878361203     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2170-2     Document Type: Article

References (48)

1. The World Health Report 2004 - Changing History (2004) World Health Organization, Geneva, pp 120-124
2. Kerkeni M, Addad F, Chauffert M et al (2006) Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 52(1):53-58
3. Schmidt HH, Walter U (1994) NO at work. Cell 78(6):919-925
4. Hingorani AD (2001) Polymorphisms in endothelial nitric oxide synthase and atherogenesis. Atherosclerosis 154(3):521-527
5. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329(27):2002-2012
6. Kugiyama K, Yasue H, Okumura K et al (1996) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94(3):266-271
7. Furlong B, Henderson AH, Lewis MJ et al (1987) Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90(4):687-692
8. Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2(8567):1057-1058
9. Yao SK, Ober JC, Krishnaswami A et al (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86(4):1302-1309
10. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 95(11):4651-4655
11. Loscalzo J, Welch G (1995) Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38(2):87-104
12. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100(9):2153-2157
13. Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489-509
14. Gryglewski RJ, Chlopicki S, Swies J et al (1995) Prostacyclin, nitric oxide, and atherosclerosis. Ann N Y Acad Sci 748:194-206
15. Williams SB, Cusco JA, Roddy MA et al (1996) Impaired nitric oxide-mediated vasodilation in patients with noninsulin-dependent diabetes mellitus. J Am Coll Cardiol 27(3):567-574
16. Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur Heart J 24(1):28-66
17. Heltianu C, Costache G, Gafencu A et al (2005) Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction. J Cell Mol Med 9(1):135-142
18. Gardemann A, Lohre J, Cayci S et al (2002) The allele of the missense 894G>T endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with atherosclerotic risk profile. Atherosclerosis 160(1):167-175
19. Tikkanen I, Fyhrquist F (1995) Nitric oxide in hypertension and renal diseases. Ann Med 27(3):353-357
20. Nakayama M, Yasue H, Yoshimura M et al (1999) T-786-C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22):2864-2870
21. Sandrim VC, de Syllos RW, Lisboa HR et al (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189(1):241-246
22. Yoshimura M, Yasue H, Nakayama M et al (1998) A missense 894G>T variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103(1):65-69
23. Hingorani AD, Liang CF, Fatibene J et al (1999) A common variant of the endothelial nitric oxide synthase (Glu298 -Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100(14):1515-1520
24. Shimasaki Y, Yasue H, Yoshimura M et al (1998) Association of the missense 894G>T variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31(7):1506-1510
25. Lembo G, De Luca N, Battagli C et al (2001) A common variant of endothelial nitric oxide synthase (894G>T) is an independent risk factor for carotid atherosclerosis. Stroke 32(3):735-740
26. Shin Shin Y, Baek SH, Chang KY et al (2004) Relations between eNOS 894G>T polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 65(3):257-265
27. Yoshimura T, Yoshimura M, Tabata A et al (2000) Association of the missense 894G>T variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig 7(4):238-241
28. Zervou S, Karteris E, Goumenou AG et al (2003) The Glu298-Asp polymorphism of the endothelial nitric oxide synthase gene is associated with endometriosis. Fertil Steril 80(6):1524-1525
29. Colomba D, Duro G, Corrao S et al (2008) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. Immun Ageing 5:4
30. Hibi K, Ishigami T, Tamura K et al (1998) Endothelial nitric oxide gene polymorphism and acute myocardial infarction. Hypertension 32(3):521-526
31. Karvonen J, Kauma H, Kervinen K et al (2002) Endothelial nitric oxide synthase gene 894G>T polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251(2):102-110
32. Andrikopoulos GK, Grammatopoulos DK, Tzeis SE et al (2008) Association of the 894G>T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med Genet 9:43
33. Wang CL, Hsu LA, Ko YS et al (2001) Lack of association between the 894G>T variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 100(11):736-740
34. Ghilardi G, Biondi ML, DeMonti M et al (2002) Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin Chem 48(7):989-993
35. Jaramillo PC, Lanas C, Lanas F et al (2008) 786T>C polymorphism of the endothelial nitric oxide synthase gene in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 387(1-2):105-108
36. Marroni AS, Metzger IF, Souza-Costa DC et al (2005) Consistent interethnic distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12(3):177-182
37. Szolnoki Z (2007) Genetic variant-associated endothelial dysfunction behind small-vessel cerebral circulatory disorders: a new pathomechanism behind common cerebral phenotypes. Mini Rev Med Chem 7(5):527-530
38. Szolnoki Z (2007) Chemical events behind leukoaraiosis: medicinal chemistry offers new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype). Curr Med Chem 14(9):1027-1036
39. Periaswamy R, Gurusamy U, Shewade DG et al (2008) Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. Clin Chim Acta 395(1-2):134-136
40. Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937-952
41. Tesauro M, Thompson WC, Rogliani P et al (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate versus glutamate at position 298. Proc Natl Acad Sci USA 97(6):2832-2835
42. McDonald DM, Alp NJ, Channon KM (2004) Functional comparison of the endothelial nitric oxide synthase 894G>T polymorphic variants in human endothelial cells. Pharmacogenetics 14(12):831-839
43. Pacanowski MA, Zineh I, Cooper-Dehoff RM et al (2009) Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension. Am J Hypertens 22(7):748-753
44. Gluba A, Banach M, Rysz J et al (2009) Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study. Angiology 60(5):588-595
45. Angeline T, Isabel W, Tsongalis GJ (2010) Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol 89(3):205-208
46. Casas JP, Cavalleri GL, Bautista LE (2006) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164(10):921-935
47. Cooke GE, Doshi A, Binkley PF (2007) Endothelial nitric oxide synthase gene: prospects for treatment of heart disease. Pharmacogenomics 8(12):1723-1734
48. Stein CM, Lang CC, Xie HG et al (2001) Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race. Pharmacogenetics 11(2):95-110